This Just In…
Two new pharmacy benefit management companies have decided to enter the market, promising to facilitate greater drug price transparency: EmsanaRx and the Mark Cuban Cost Plus Drug Company.
Pharmacy benefit managers (PBMs) work with insurance companies, pharmacies, and manufacturers to negotiate the lowest drug costs for their members. Drug Channels Institute estimates that in 2020 about 77 percent of all prescription claims ran through the top three PBMs — CVS Health, the Express Scripts business of Cigna, and the OptumRx business of UnitedHealth Group.
EmsanaRx is a nonprofit coalition of almost 40 companies planning to offer pharmacy benefit management services to employers. EnsanaRx, which includes retailers such as Walmart and Costco, is the PBM unit of the Purchaser Business Group on Health (PBGH) coalition. Emsana Health plans to serve as an “innovation studio” which will develop new products and solutions with input from PBGH’s employer members.
The goal of the Mark Cuban Cost Plus Drug Company is to sell generic drugs at a transparent, fixed rate, and to unite manufacturing, distribution, and pharmacy services under one roof. The PBM plans to be running by 2023, according to an article in the Wall Street Journal.
Copyright © 2020 Smarts Publishing
About the Author
Share This Story
Related Blogs
PCORI Fees: What Employers Should Know Before the July Filing Deadline
The Affordable Care Act established the Patient-Centered Outcomes Research Institute (PCORI) to support research evaluating the effectiveness of medical treatments and healthcare delivery. To help fund this work, certain employer-sponsored health plans must pay an annual PCORI fee.
Iran Conflict Drives Cyberattacks, Highlighting Security Preparedness
As the Iranian conflict continues to unfold, cyberattacks on businesses and infrastructure continue to escalate. On March 12, a cyberattack targeted medical technology company Stryker Corporation, reportedly wiping more than 200,000 devices worldwide and deleting 50 terabytes of corporate data.
Insurers Turn to Telematics to Address Rising Commercial Auto Losses
Amid a steep rise in accident severity and litigation costs, commercial auto insurers are turning to telematics technology to improve risk assessment and help stabilize a market under financial strain.